Aquestive Therapeutics Inc. (NASDAQ: AQST) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AQUESTIVE THERAPEUTICS INC.

Aquestive Therapeutics Inc. (NASDAQ: AQST)
Listen to this Section


$4.24
+0.0150 ( +0.36% ) 505.7K

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Clinical Trial Pipeline Stages


Drug Name Stage
LIBERVANT™ (Diazepam) Buccal FilmDetailsSeizures Approved
ZUPLENZ (ondansetron)DetailsNausea and vomiting Approved
KYNMOBI™ (apomorphine HCI) sublingual film (APL-130277)DetailsParkinson’s disease (OFF Episodes / motor fluctuations) Approved
Exservan™ (riluzole) Oral FilmDetailsAmyotrophic Lateral Sclerosis (ALS) Approved
SUBOXONE (buprenorphine/naloxone)DetailsOpioid addiction Approved
AQST-108 (epinephrine) Topical GelDetailsSkin disease/disorder Phase 1
AQST-119DetailsErectile dysfunction Failed

Market Data


Open $4.24
Previous Close $4.22
Volume 505.7K
Market Cap $529.40M
Day Range $4.13 - $4.29
52 Week Range $2.93 - $7.55
Shares Outstanding 125.45M
Change % +0.36%
Net Change ▲ 0.0150
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2018
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -2,092,127.00

Date Type Amount Purchased Purchaser
2024-03-11 Sale -1981.00 Wargacki Stephen
2024-03-11 Sale -86250.00 Boyd Peter E.
2024-03-11 Sale -1365.00 Jung Cassie
2024-03-11 Sale -242600.00 Barber Daniel
2024-03-11 Sale -112500.00 Kraus Carl N
2024-03-11 Sale -82500.00 Schobel Alexander Mark
2023-08-09 Sale -75000.00 BRAENDER LORI J
2023-08-09 Sale -70000.00 TOTH A ERNEST JR
2023-08-09 Sale -75000.00 Marshall Ken W.
2023-08-09 Sale -50000.00 Boyd Peter E.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 17 Mar 30, 2026
8-k 8K-related 15 Mar 20, 2026
4 Insider transactions 1 Mar 11, 2026
4 Insider transactions 1 Mar 11, 2026
4 Insider transactions 1 Mar 11, 2026
4 Insider transactions 1 Mar 11, 2026
3 Insider transactions 2 Mar 11, 2026
4 Insider transactions 1 Mar 11, 2026
4 Insider transactions 1 Mar 11, 2026
4 Insider transactions 1 Mar 11, 2026

Latest News


× Before browsing our site, please accept our cookies policy